Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method-Reference-Cited by-同舟云学术

Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method

Published:2023-04-05 Issue:5 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Tian Cuimeng¹,Liu Guimei¹,Xu Yongxiang¹,Xia Guangrong¹,Zhang Tongmei²,Huang Jiaqiang³,Liu Fangchao⁴,Li Baolan⁵

Affiliation:

1. Department of Radiation Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China

2. Department of General Medicine, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China

3. Laboratory of Cancer Basic Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China

4. Department of Scientific Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China

5. Department of General Medicine, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference29 articles.

1. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer;Goldstraw;J Thorac Oncol,2016

2. The IASLC lung cancer staging project: Validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Groome;J Thorac Oncol,2007

3. Radiotherapy treatment for lung cancer: Current status and future directions;Vinod;Respirology,2020

4. Five-Year survival outcomes from the PACIFIC Trial: Durvalumab after chemoradiotherapy in stage III Non-Small-Cell lung cancer;Spigel;J Clin Oncol,2022

5. Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group;Postoperative radiotherapy in non-small-cell lung cancer;Lancet,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of clinically significant cardiovascular disease associated with postoperative radiotherapy in non-small cell lung cancer patients receiving surgical resection followed by adjuvant chemotherapy: A Korean nationwide cohort study;Radiotherapy and Oncology;2024-06